Asia-Pacific countries have an immense growth potential to emerge as hubs for the development of new generation pharmaceuticals, biotech products and diagnostics. In fact, these countries are fast gaining recognition as perfect destinations for outsourcing of clinical trials, contract research and contract manufacturing. As per our new research report "Asia Pacific Biotechnology Market (2008-2012)", the Asia Pacific biotech market is projected to grow at a CAGR of around 14% during 2010-2012.
We have done an extensive research and analysis of the Asia Pacific biotechnology market, with focus on providing insight into the present industry trends and developments. As per the report, the key biotechnology markets in Asia Pacific region are - India, China, Japan, Malaysia, Singapore and Korea. These countries have been continuously receiving high investments from all around the world in various segments of the biotechnology market. Most of the governments have acknowledged the benefits of biotechnology and are giving strong support to attract more investments from private players. Moreover, the governments are framing favorable industry policies and taking all necessary steps to win confidence of investors.
The report also provides comprehensive information of various market drivers in these countries. For instance - the improvement of IPR regime and low cost of skilled manpower are two major factors driving growth in the industry. All the Asia Pacific countries have realized the essentiality of strong IPR regime to attract more multinational companies in the biotechnology market. Besides, the report gives an overview of emerging market segments like Contract Research, Vaccines, Generics, Stem Cell Research, Nanotechnology and Bioinformatics.
"Asia Pacific Biotechnology Market (2008-2012)" contains extensive research, rational analysis, authentic data and reliable statistics of biotechnology industries in the Asia Pacific region. It also identifies various roadblocks restraining growth of the market to give an unbiased analysis. It also provides information of key players along with their business overview, which will help clients while devising their business strategies. The report also discusses the success and risk factors of each country's biotechnology market and includes future outlook. The future outlook section gives a rough idea of the direction in which the biotechnology industry is likely to move in coming years. Thus, the report will assist individual investors, consultants, managers and companies to make right decision.
For more information visit: http://www.rncos.com/Report/IM138.htm |
